Anne-Marie Koop

3 99 77. Lewandowski ED, Fischer SK, FasanoM, Banke NH,Walker LA, Huqi A,Wang X, Lopaschuk GD, O’Donnell JM. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy. Circ Res 2013;112:57–65. 78. Talati M, Hemnes A. Fatty acid metabolism in pulmonary arterial hypertension : role in right ventricular dysfunction and hypertrophy. Pulm Circ 2015; l :269–278. 79. Brittain EL, Talati M, Fessel JP, Zhu H, Penner N, Calcutt MW, West JD, Funke M, Lewis GD, Gerszten RE, Hamid R, Pugh ME, Austin ED, Newman JH, Hemnes AR. Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension. Circulation E.L. Brittain, Division of Cardiovascular Medicine, Vanderbilt University Medical School, Nashville, United States; 2016;133:1936–1944. 80. Bitar FF, Bitar H, Sabban M El, Nasser M, Yunis KA, Tawil A, Dbaibo GS. Modulation of ceramide content and lack of apoptosis in the chronically hypoxic neonatal rat heart. Pediatr Res F.F. Bitar, Department of Pediatrics, American University of Beirut, Beirut, Lebanon; 2002;51:144–149. 81. Huss JM, Gigue V, Kelly DP. Estrogen-Related Receptor ␣ Directs Peroxisome Proliferator- Activated Receptor ␣ Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle. Society 2004;24:9079–9091. 82. Burkart EM, Welch MJ, Kelly DP, Burkart EM, Sambandam N, Han X. Nuclear receptors PPAR b / d and PPAR a direct distinct metabolic regulatory programs in the mouse heart Find the latest version : Nuclear receptors PPAR β / δ and PPAR α direct distinct metabolic regulatory programs in the mouse heart. 2007;117:3930–3939. 83. Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, Febbraio M, Finck BN, Kelly DP. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 2007; 100 :1208–1217. 84. Duncan JG, Bharadwaj KG, Fong JL, Mitra R, Sambandam N, Courtois MR, Lavine KJ, Goldberg IJ, Kelly DP. Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor- ␣ Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-a Activators. Circulation 2010;121:426–435. 85. Sharma S, Adrogue J V., Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004;18:1692–1700. 86. Urashima T, Zhao M, Wagner R, Fajardo G, Farahani S, Quertermous T, Bernstein D, Quertermous T, Molecular BD. Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. 2008;94304. 87. Friehs I, Cowan DB, Choi Y-H, Black KM, Barnett R, Bhasin MK, Daly C, Dillon SJ, Libermann TA, McGowan FX, Nido PJ del, Levitsky S, McCully JD. Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. AJP Hear Circ Physiol 2013;304:H697-708. 88. Kreymborg K grosse, Uchida S, Gellert P, Schneider A, Boettger T, Voswinckel R, Wietelmann A, Szibor M, Weissmann N, Ghofrani AH, Schermuly R, Schranz D, Seeger W, Braun T. Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. J Mol Cell Cardiol Elsevier Ltd; 2010;49:598–605.